Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
As of 2026-05-03, Phathom Pharmaceuticals Inc. (PHAT) is trading at $12.01, marking a 7.23% gain in recent trading sessions. This analysis outlines key market context, technical support and resistance levels, and potential near-term scenarios for the stock, without offering investment advice. No recent earnings data is available for PHAT as of this date, so recent price movement has been driven largely by short-term trading flows and broader sector sentiment rather than quarterly financial perfo
Why Phathom Pharmaceuticals (PHAT) might be the steady performer you need (Investor Interest) 2026-05-03 - Crowd Entry Points
PHAT - Stock Analysis
4012 Comments
1774 Likes
1
Raign
Insight Reader
2 hours ago
Indices remain in a consolidation zone, providing potential opportunities for range-bound traders.
👍 14
Reply
2
Kesa
Legendary User
5 hours ago
I read this and now I’m thinking deeply for no reason.
👍 265
Reply
3
Britta
Elite Member
1 day ago
I wish I had caught this in time.
👍 236
Reply
4
Khiry
Influential Reader
1 day ago
Hard work really pays off, and it shows.
👍 247
Reply
5
Toribio
Power User
2 days ago
This feels like I skipped an important cutscene.
👍 115
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.